To investigate the patient Quality of Life and satisfaction outcomes of combined cataract surgery with retinal surgery for visually significant epiretinal membrane in patients receiving Vivity IOL versus standard monofocal controls.
Adult patients with visually significant epiretinal membrane who are undergoing or have already had pars plana vitrectomy and membrane peel combined with cataract surgery using Clareon Vivity and Clareon Vivity Toric IOLs or monofocal IOL
IOL powers between +6D to +30.0D, T3-T6
History of ocular or refractive surgery
Other ocular or systemic comorbidities that may alter or reduce visual acuity and contrast sensitivity, such as severe dry eye/ocular surface disease, glaucoma, macular degeneration, retinopathy, neuro-ophthalmic diseases, strabismus/amblyopia etc.
Patients with irregular astigmatism, corneal dystrophies, pupil abnormalities, zonular laxity
Intraoperative or postoperative complications
Debbie Kuo, MD
Lead sponsor
Sutter Health
Sponsor institution